As expected, the Nevada State Athletic Commission has ended Alistair Overeem’s (Pictured) nine-month testosterone suspension. The committee voted unanimously during Tuesday’s hearing to reissue the UFC heavyweight his fight license, green lighting his February 2nd scrap against Antonio “Bigfoot” Silva.
Last March, the NSAC sprung a surprise drug test on the six featured fighters appearing in UFC 146. The results from the pop quiz revealed Overeem’s ‘A’ sample registered a Testosterone/Epitestosterone (T/E) ratio of 14:1, which is more than double the legal limit permitted by Nevada’s governing body.
According to NSAC executive director Keith Kizer, Overeem bolted for his car immediately after the presser wrapped to try and avoid the surprise exam.
Overeem was slated to challenge then-champion Junior dos Santos for his hardware in the show’s featured attraction.
Prior to being handed his suspension in April, Overeem revealed anti-inflammatory medication he used to treat his injured rib is what caused him to produce elevated levels of testosterone. The veteran claimed he was unaware of what he was injecting in his body.
Kizer revealed today that Overeem submitted five voluntary tests between June and November. He was also subjected to NSAC-administered blood and urine screenings on November 16th and December 21st. All results were negative.
Overeem and Bigfoot co-headline UFC 156. It is believed “The Demolition Man” will earn first dibs at Cain Velasquez’s 265-pound crown if he emerges victorious.
Mandalay Bay Events Center in Las Vegas hosts the shootout.